Recently, investment analysts covering the stock have updated the mean rating to 3.
Advertisement
(NYSE:STJ), jumped 0.24% and closed at $78.01 in the last trading session. This insider holds 125,027 shares with a market value around $9753356 as of recent close. The stock now shows the Market Capitalization of 60.05 Billion. Argus reiterated a “hold” rating on shares of St. Jude Medical in a report on Monday, May 2nd.
Morgan Stanley (NYSE:MS)’s earnings per share growth ratio for the past 5 years was noted as 3.4% while revenue increase for the past 5 years was 0.1%. For the past 5 years, the company’s revenue has grown 1.4%, while the company’s earnings per share has grown 2.3%. During the same quarter in the previous year, the company posted $1.07 EPS.
Many Wall Street Analysts have commented on St. Jude Medical.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be given a $0.31 dividend. The company has dropped -1.02% in past 3 months and in the last five trades has moved up 0.41%. The ex-dividend date is Wednesday, September 28th.
A number of other research firms have also weighed in on STJ. Wells Fargo & Co. reiterated a “hold” rating on shares of St. Jude Medical in a report on Saturday, April 30th. The stock’s Dividend stands at 0.8 and Dividend Yield stands at 2.55 Percent.
St. Jude Medical CEO Michael Rousseau on Tuesday said a short-selling investment firm and its hired hackers are acting irresponsibly and unnecessarily frightening patients by raising false concerns about whether the Minnesota company’s pacemakers and implantable defibrillators are vulnerable to computer hacking. Barclays PLC increased their target price on St. Jude Medical from $80.00 to $83.00 and gave the stock an equal weight rating in a research note on Thursday, July 21st. Finally, JPMorgan Chase & Co. reiterated a “hold” rating on shares of St. Jude Medical in a report on Sunday, July 17th. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
Several hedge funds have bought and sold shares of STJ.
Advertisement
St. Jude Medical (STJ): Alpine Associates Management added new position in St. Jude Medical during the most recent quarter end. Balyasny Asset Management LLC bought a new stake in shares of St. Jude Medical during the fourth quarter valued at about $57,252,000. St. Jude Medical makes up approx 0.07% of South Dakota Investment Council’s portfolio.Columbia Partners L L C Investment Management boosted its stake in STJ in the latest quarter, The investment management firm added 418 additional shares and now holds a total of 16,254 shares of St. Jude Medical which is valued at $1,359,485. MA now owns 21,548,993 shares of the medical technology company’s stock valued at $1,331,081,000 after buying an additional 1,818,614 shares during the last quarter. BP PLC boosted its stake in St. Jude Medical by 73.3% in the second quarter. The stock has relative volume of 4.72.
